Clinical Trials Arena August 28, 2024
GlobalData

The number of new oesophageal cancer cases annually is projected to increase by 80% before 2050. Find out about current and developing treatments set to improve patient outcomes.

Oesophageal cancer is the 11th most diagnosed cancer and the 7th leading cause of cancer mortality. The disease starts in the oesophagus, the tube that moves food from the throat to the stomach, but symptoms often remain unnoticed until the cancer spreads. The two main types, oesophageal adenocarcinoma, and oesophageal squamous cell carcinoma, develop in different oesophageal regions and are driven by distinct genetic changes.

The prevalence of oesophageal cancer

Oesophageal cancer is more common in men than women, with global Age Standardised Incidence Rates (ASIR) of 7.6 and 2.6 respectively. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
Challenges and Opportunities for Digital Innovation in Clinical Trials
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
New NIH tool uses genAI to connect volunteers with clinical trials
Medtronic, Tempus testing AI to find potential TAVR patients
Legal and ethical challenges in AI-driven clinical trials

Share This Article